logo

Ascendis Pharma A/S (ASND)



Trade ASND now with
  Date
  Headline
4/1/2020 4:08:27 PM Ascendis Pharma A/S FY19 Loss/share EUR 4.69 Vs. Loss EUR 3.17 Year Ago
1/12/2020 8:50:56 PM Ascendis Pharma A/S Provides Pipeline Update And Reviews Progress Towards Vision 3x3
11/18/2019 4:10:57 PM Ascendis Pharma Q3 Loss/share EUR 0.53 Vs. Loss EUR 0.81 Year Ago
8/28/2019 4:18:24 PM Ascendis Pharma Q2 Loss/share EUR 1.25 Vs. Loss EUR 0.55 Year Ago
6/3/2019 7:30:32 AM Wedbush Is Increasing Ascendis Pharma A/S (ASND) FY19 Rev. Estimate To 5.5 M From 0.1 M
6/3/2019 7:30:07 AM Wedbush Is Cutting Ascendis Pharma A/S (ASND) FY20 Estimate To -4.33 From -4.27
6/3/2019 7:29:55 AM Wedbush Is Lowering Ascendis Pharma A/S (ASND) Q4 20 Estimate To -1.12 From -1.11
6/3/2019 7:29:42 AM Wedbush Is Cutting Ascendis Pharma A/S (ASND) Q3 20 Estimate To -1.10 From -1.08
6/3/2019 7:27:02 AM Wedbush Is Cutting Ascendis Pharma A/S (ASND) Q2 20 Estimate To -1.07 From -1.05
6/3/2019 7:26:46 AM Wedbush Is Cutting Ascendis Pharma A/S (ASND) Q1 20 Estimate To -1.05 From -1.03
6/3/2019 7:25:58 AM Wedbush Is Increasing Ascendis Pharma A/S (ASND) FY19 Estimate To 2.75 From -3.91
6/3/2019 7:25:24 AM Wedbush Is Increasing Ascendis Pharma A/S (ASND) Q4 19 Estimate To 0.39 From -1.04
6/3/2019 7:25:13 AM Wedbush Is Raising Ascendis Pharma A/S (ASND) Q3 19 Estimate To 0.39 From -1.03
6/3/2019 7:24:59 AM Wedbush Is Raising Ascendis Pharma A/S (ASND) Q2 19 Estimate To 0.43 From -0.94
6/3/2019 7:24:32 AM Wedbush Reiterates Ascendis Pharma A/S (ASND) At Outperform With $223 Up From $219 Price Target
  
 
>